Key result
Initial response to enhanced external counterpulsation predicted sustained 1-year angina improvement and freedom from major adverse cardiovascular events.
Why the study?
What are the predictors of sustained 1-year clinical benefit after enhanced external counterpulsation in patients with angina?
Cohort (n=2,007)
Yes
What are the predictors of sustained 1-year clinical benefit after enhanced external counterpulsation in patients with angina?
Initial response to enhanced external counterpulsation and absence of congestive heart failure are strong predictors of sustained angina improvement and freedom from MACE at 1 year.
Answers are grounded in this paper and cite their sources.
Initial response may identify angina patients for enhanced external counterpulsation; hypothesis-generating and requires randomized confirmation.
Enhanced external counterpulsation (EECP) has been shown to reduce Canadian Cardiovascular Society angina class. This study examines the factors that affect the reduction at 1 year, especially in patients who do not demonstrate an initial response. The data of 2,007 consecutive patients enrolled in the International EECP Patient Registry were analyzed. After 36.6 +/- 4.9 h of EECP, angina was reduced by at least one class in 82.7%. At 1 year, 35.4% of initial nonresponders and 70.6% of responders remained improved by at least one angina class and free of major adverse cardiovascular events. Multivariate predictors of 1-year benefit are initial response to treatment (odds ratio 4.5, 95% CI 3.5-5.8), baseline angina class compared with class IV (odds ratios: class I 2.1, CI 0.93-4.81; class II 0.62, CI 0.43-0.87; class III 0.80, CI 0.62-1.01) and no history of congestive heart failure (odds ratio 1.41, CI 1.14-1.74).
No takes yet. Share an insight, caveat, or question.
Lawson et al. (2005) conducted a cohort in Angina (n=2,007). Initial response to Enhanced external counterpulsation (EECP) vs. Initial nonresponders was evaluated on Improved by at least one angina class and free of major adverse cardiovascular events at 1 year (OR 4.5, 95% CI 3.5-5.8). Initial response to enhanced external counterpulsation predicted sustained 1-year angina improvement and freedom from major adverse cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: